BIOA
Ticker
BioAge Labs, Inc.
BIOA · Healthcare · BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseasesBioAge Labs, Inc. (BIOA), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 8 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 30 and filed Jul 1. The most active filer was Paul D Rubin with 5 filings.
Add to watchlistFilings, ttm
8
0 buys · 8 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$7.6M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jun 30
Filed Jul 1
ADViAverage daily dollar volume
$8.8M
market data
Share price · 12M
$9.38 (+83.6%)
Adjusted for splits and dividends.
Volume by month
Buys $12.4M
Sells $7.6M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
PR
Paul D Rubin
Chief Medical Officer
5 filings
VP
Vijay Satyanand Pande
Director
2 filings
SB
Shane Barton
Principal Accounting Officer
1 filing
BCRecent filings
Shane BartonSALE
Principal Accounting Officer
$1.6M62,566 sh across 2 lots
Exec Jun 29
Filed Jul 1 · 4:27 PM ET Paul D RubinSALE Chief Medical Officer $157K
8,820 sh × $17.81
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Paul D RubinSALE Chief Medical Officer $151K
7,433 sh × $20.30
Exec Mar 2
Filed Mar 3 · 5:30 PM ET Paul D RubinSALE Chief Medical Officer $139K
7,433 sh × $18.75
Exec Feb 2
Filed Feb 3 · 5:30 PM ET Kristen FortneySALE Chief Executive Officer $4.2M
233,107 sh × $18.12
Exec Jan 13
Filed Jan 15 · 5:30 PM ET Dov A Md GoldsteinSALE Chief Financial Officer $405K
20,637 sh across 2 lots
Exec Jan 13
Filed Jan 15 · 5:30 PM ET Paul D RubinSALE Chief Medical Officer $216K
18,000 sh × $12.00
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET Paul D RubinSALE Chief Medical Officer $702K
68,897 sh × $10.19
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Vijay Satyanand PandePURCHASE Director $4.3M
219,195 sh across 3 lots
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET Bihua ChenPURCHASE Other $8.1M
450,000 sh × $18.00
Exec Sep 27 2024
Filed Oct 1 2024 · 5:30 PM ET James HealyPURCHASE Director $12.0M
666,665 sh across 5 lots
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET Patrick G EnrightPURCHASE Director $7.2M
400,000 sh × $18.00
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET Vijay Satyanand PandePURCHASE Director $16.2M
900,000 sh × $18.00
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET